Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Bioheart (BHRT)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for BHRT as compared to
Top Competitors
Biotechnology
Pharma & healthcare
Pharmaceuticals
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
231K
LOW
EBITDA
►
-5.17M
LOW
Net Income
►
-8.38M
HIGH
Revenue Growth
►
114.7%
LOW
Operating Margin
►
-2697.8%
AVG
Net Margin
►
-3626.8%
LOW
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-1.09
Current Ratio
►
0.0399
LOW
Quick Ratio
►
0.0224
LOW
Interest Coverage Ratio
►
-2.74
AVG
Book Value Per Share
►
-0.842
Cash Per Share
►
0.00446
Loading...
STOCK SUMMARY
Open
0.89
Day Range
0.80
-
0.89
52 Week Range
0.30
-
2.50
Volume
400
Avg Volume (3 mo)
35K
Shares Outstanding
19.5M
Market Cap
17.4M
VALUATION
Price to Earnings (P/E)
►
-2.10
Price to Book (P/B)
►
-1.06
Price to Sales (P/S)
►
76.0
AVG
Return on Assets (ROA)
►
-268.7%
LOW
EV/EBITDA
►
-4.37
Dividend Yield
0%
AVG
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
4.3%
Net Insider Buying 1yr
6.3%
Held by insiders
76.7%
Held by institutions
1.4%
No Sales Breakout Data.